Need Training?

Build a solid foundation in science, formulation and product development—find out more!

Most Popular in:

Patents

Email This Item! Print This Item!

Patent Picks—Etyllinoleate, Dibenzoyl Peroxide, Pentane-1,5-Diol, Microcapsules and More for Treating Acne

By: Katie Anderson (Schaefer), Cosmetics & Toiletries magazine
Posted: July 12, 2011

page 3 of 5

Dibenzoyl peroxide derivatives, preparation method thereof and cosmetic or dermatological compositions containing same
WIPO Patent Application WO/2011/080469
Publication Date: July 7, 2011
Assignee: Galderma Research & Development, N Rodeville, J PASCAL,  and C Biouix-Peter 

The invention relates to the use of compounds with a general formula. The invention also relates to the preparation method thereof and to the cosmetic or dermatological use of same. The compounds of the invention act as bactericidal agents. Consequently, said compounds can be used in the treatment of conditions associated with the presence of bacteria, specifically P. acnes.

Composition based on etyllinoleate and triethylcitrate for the treatment of seborrhea and acne
European Patent EP1455899
Publication Date: July 6, 2011
Assignee: General Topics S.R.L.

The object of the invention is to provide a new product characterized by being highly efficacious with excellent cutaneous tolerability, in particular in the treatment of seborrhoea, acne and acne rosacea. The object is achieved, according to the invention, with a composition containing an active ingredient mixture including the ethyl ester of linoleic acid (ethyllinoleate) and triethylester of citric acid (triethylcitrate). This composition results as being able, among other things, to inhibit the activity of specific enzymes, such as 5-alpha reductase, lipase and esterase, enabling a control of the seborrhoea and in general the evolution of the acneic and rosacea picture.

Method for inhibiting the growth of antibiotic resistant of bacteria by using pentane-1,5-diol
US Patent 7973080
Publication Date: July 5, 2011
Assignee: Ambria Dermatology AB